89bio, Inc. Annual Operating Income (Loss) in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
89bio, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2018 to 2023.
  • 89bio, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$53.4M, a 26.8% decline year-over-year.
  • 89bio, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$191M, a 55.4% decline year-over-year.
  • 89bio, Inc. annual Operating Income (Loss) for 2023 was -$151M, a 47.9% decline from 2022.
  • 89bio, Inc. annual Operating Income (Loss) for 2022 was -$102M, a 13.9% decline from 2021.
  • 89bio, Inc. annual Operating Income (Loss) for 2021 was -$89.7M, a 81.8% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$151M -$49M -47.9% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-01
2022 -$102M -$12.5M -13.9% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-01
2021 -$89.7M -$40.4M -81.8% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-01
2020 -$49.4M -$22.7M -85.3% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-24
2019 -$26.6M -$11.5M -75.7% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-25
2018 -$15.2M Jan 18, 2018 Dec 31, 2018 10-K 2020-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.